Nonoperating Income (Expense) of ACCENDRA HEALTH INC/VA/ from 30 Sep 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
ACCENDRA HEALTH INC/VA/ quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 30 Sep 2018 to 31 Dec 2025.
  • ACCENDRA HEALTH INC/VA/ Nonoperating Income (Expense) for the quarter ending 31 Dec 2025 was $685,000, a 53% increase year-over-year.
  • ACCENDRA HEALTH INC/VA/ Nonoperating Income (Expense) for the twelve months ending 31 Dec 2025 was $3,942,000, a 14% increase year-over-year.
  • ACCENDRA HEALTH INC/VA/ annual Nonoperating Income (Expense) for 2025 was $3,942,000, a 14% increase from 2024.
  • ACCENDRA HEALTH INC/VA/ annual Nonoperating Income (Expense) for 2024 was $4,589,000, a 283% decline from 2023.
  • ACCENDRA HEALTH INC/VA/ annual Nonoperating Income (Expense) for 2023 was $1,197,000, a 62% increase from 2022.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $3,942,000 $685,000 +$767,000 +53% 01 Oct 2025 31 Dec 2025 10-K 20 Feb 2026 2025 FY
Q3 2025 $4,709,000 $1,076,000 +$92,000 +7.9% 01 Jul 2025 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $4,801,000 $942,000 -$126,000 -15% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $4,675,000 $1,239,000 -$86,000 -7.5% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,589,000 $1,452,000 +$588,000 +29% 01 Oct 2024 31 Dec 2024 10-K 20 Feb 2026 2025 FY
Q3 2024 $5,177,000 $1,168,000 -$4,470,000 -135% 01 Jul 2024 30 Sep 2024 10-Q 31 Oct 2025 2025 Q3
Q2 2024 $707,000 $816,000 +$256,000 +24% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $963,000 $1,153,000 +$234,000 +17% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $1,197,000 $2,040,000 -$1,258,000 -161% 01 Oct 2023 31 Dec 2023 10-K 20 Feb 2026 2025 FY
Q3 2023 $61,000 $3,302,000 +$4,085,000 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024 2024 Q3
Q2 2023 $4,024,000 $1,072,000 -$289,000 -37% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 $3,735,000 $1,387,000 -$604,000 -77% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q4 2022 $3,131,000 $782,000 +$18,000 +2.2% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $3,149,000 $783,000 +$16,000 +2% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $3,165,000 $783,000 +$245,000 +24% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $3,410,000 $783,000 -$214,000 -38% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $3,196,000 $800,000 -$15,000 -1.9% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
Q3 2021 $3,181,000 $799,000 -$14,000 -1.8% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $3,167,000 $1,028,000 -$3,724,000 -138% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $557,000 $569,000 +$150,000 +21% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $407,000 $785,000 -$1,873,000 -172% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $2,280,000 $785,000 -$235,000 -43% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $2,515,000 $2,696,000 +$3,427,000 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q1 2020 $912,000 $719,000 +$2,015,000 +74% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $2,927,000 $1,088,000 01 Oct 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
Q3 2019 $550,000 -$550,000 01 Jul 2019 30 Sep 2019 10-Q 03 Nov 2020 2020 Q3
Q2 2019 $731,000 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $2,734,000 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q3 2018 $0 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3

ACCENDRA HEALTH INC/VA/ Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $3,942,000 +$647,000 +14% 01 Jan 2025 31 Dec 2025 10-K 20 Feb 2026 2025 FY
2024 $4,589,000 -$3,392,000 -283% 01 Jan 2024 31 Dec 2024 10-K 20 Feb 2026 2025 FY
2023 $1,197,000 +$1,934,000 +62% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2026 2025 FY
2022 $3,131,000 +$65,000 +2% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $3,196,000 -$3,603,000 -885% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $407,000 +$3,334,000 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $2,927,000 +$838,000 +22% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $3,765,000 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.